Skip to main content
TipRanks
Go Ultimate75% OFF

Kiniksa Pharmaceuticals (KNSA) Ratios

620 Followers

Kiniksa Pharmaceuticals Ratios

KNSA's free cash flow for Q3 2026 was $47.10M. For the 2026 fiscal year, KNSA's free cash flow was decreased by $-180.00K and operating cash flow was $47.28M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio3.793.304.345.164.38
Quick Ratio3.393.043.854.714.30
Cash Ratio1.191.821.702.612.73
Solvency Ratio0.31-0.290.192.92-3.26
Operating Cash Flow Ratio0.180.260.210.12-2.82
Short-Term Operating Cash Flow Coverage8.600.000.000.000.00
Net Current Asset Value$ 331.15M$ 189.68M$ 188.81M$ 179.54M$ 148.68M
Leverage Ratios
Debt-to-Assets Ratio0.010.020.020.010.03
Debt-to-Equity Ratio0.020.020.030.010.03
Debt-to-Capital Ratio0.020.020.030.010.03
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio1.351.321.201.161.26
Debt Service Coverage Ratio20.270.000.000.000.00
Interest Coverage Ratio0.000.000.000.000.00
Debt to Market Cap0.000.000.000.000.00
Interest Debt Per Share0.130.140.170.090.09
Net Debt to EBITDA-1.735.044.19-9.590.75
Profitability Margins
Gross Profit Margin54.63%85.61%79.09%89.60%76.39%
EBIT Margin13.12%-8.54%-9.32%4.44%-406.38%
EBITDA Margin13.35%-8.14%-8.46%5.53%-400.27%
Operating Profit Margin11.40%-10.78%-9.32%4.44%-406.38%
Pretax Profit Margin13.12%-8.54%-6.16%5.01%-406.13%
Net Profit Margin8.71%-10.21%5.21%83.28%-409.72%
Continuous Operations Profit Margin8.71%-10.21%5.21%83.28%-409.72%
Net Income Per EBT66.40%119.48%-84.58%1663.01%100.88%
EBT Per EBIT115.08%79.25%66.09%112.82%99.94%
Return on Assets (ROA)7.73%-7.44%2.68%39.89%-67.84%
Return on Equity (ROE)10.40%-9.85%3.21%46.29%-85.35%
Return on Capital Employed (ROCE)12.37%-9.50%-5.45%2.37%-83.33%
Return on Invested Capital (ROIC)8.17%-9.47%4.58%2.35%-81.86%
Return on Tangible Assets7.88%-7.65%2.77%41.54%-73.95%
Earnings Yield1.93%-3.06%1.15%17.64%-19.57%
Efficiency Ratios
Receivables Turnover43.4510.1412.7110.849.67
Payables Turnover151.5829.876.852.904.87
Inventory Turnover5.602.311.821.062.48
Fixed Asset Turnover57.6738.3421.3431.264.60
Asset Turnover0.890.730.510.480.17
Working Capital Turnover Ratio2.191.911.321.270.17
Cash Conversion Cycle71.17181.75176.44252.09110.22
Days of Sales Outstanding8.4035.9828.7233.6837.74
Days of Inventory Outstanding65.18157.98200.97344.34147.40
Days of Payables Outstanding2.4112.2253.25125.9374.93
Operating Cycle73.58193.97229.69378.02185.14
Cash Flow Ratios
Operating Cash Flow Per Share0.350.360.190.08-1.84
Free Cash Flow Per Share0.340.360.190.08-2.14
Dividend Paid and CapEx Coverage Ratio92.7492.74102.3255.30-6.19
Capital Expenditure Coverage Ratio92.7492.74102.3255.30-6.19
Operating Cash Flow Coverage Ratio2.702.611.090.98-20.88
Operating Cash Flow to Sales Ratio0.040.060.050.03-3.28
Free Cash Flow Yield0.83%1.80%1.07%0.55%-18.18%
Valuation Ratios
Price-to-Earnings (P/E) Ratio51.56-32.9787.255.67-5.11
Price-to-Sales (P/S) Ratio4.523.344.554.7220.94
Price-to-Book (P/B) Ratio5.393.222.802.624.36
Price-to-Free Cash Flow (P/FCF) Ratio120.4555.5993.30182.28-5.50
Price-to-Operating Cash Flow Ratio119.1555.0092.39178.98-6.39
Price-to-Earnings Growth (PEG) Ratio-0.220.08-0.94-0.030.43
Enterprise Value Multiple32.12-35.96-49.5875.77-4.48
Enterprise Value2.90B1.24B1.13B922.55M690.73M
EV to EBITDA32.12-35.96-49.5875.77-4.48
EV to Sales4.292.934.194.1917.92
EV to Free Cash Flow114.3048.7686.03161.79-4.71
EV to Operating Cash Flow113.0748.2385.19158.87-5.47
Tangible Book Value Per Share7.445.916.025.452.42
Shareholders’ Equity Per Share7.656.146.265.712.70
Tax and Other Ratios
Effective Tax Rate0.34-0.191.85-15.63-0.01
Revenue Per Share9.135.933.863.170.56
Net Income Per Share0.80-0.600.202.64-2.30
Tax Burden0.661.19-0.8516.631.01
Interest Burden1.001.000.661.131.00
Research & Development to Revenue0.140.260.280.302.58
SG&A to Revenue0.290.400.000.000.00
Stock-Based Compensation to Revenue0.050.070.100.110.65
Income Quality-0.59-0.590.940.030.80

Currency in USD